Temozolomide as salvage treatment in primary brain lymphomas

Methotrexate (MTX)-based chemotherapy extends survival in patients with primary brain lymphomas, but it is not clear whether multiagent chemotherapy is superior to MTX alone. Treatment options for patients with recurrent primary brain lymphoma are limited; there is no standard second-line chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Reni, M, Zaja, F, Mason, W, Perry, J, Mazza, E, Spina, M, Bordonaro, R, Ilariucci, F, Faedi, M, Corazzelli, G, Manno, P, Franceschi, E, Pace, A, Candela, M, Abbadessa, A, Stelitano, C, Latte, G, Ferreri, A J M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360092/
https://www.ncbi.nlm.nih.gov/pubmed/17325700
http://dx.doi.org/10.1038/sj.bjc.6603660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360092/
https://www.ncbi.nlm.nih.gov/pubmed/17325700
http://dx.doi.org/10.1038/sj.bjc.6603660

Ejemplares similares